Bacterial Vaginosis — Time to Treat Male Partners

Bacterial vaginosis, the most common cause of vaginal discharge in reproductive-age women,1 is associated with multiple consequential adverse outcomes, including an increased risk of adverse birth outcomes, acquisition of human immunodeficiency virus and other sexually transmitted infections (STIs), pelvic inflammatory disease, and a high incidence of symptomatic recurrence.2 Bacterial vaginosis is characterized as a polymicrobial vaginal dysbiosis due to a decrease in protective lactobacillus species and an increase in facultative and strictly anaerobic bacteria.3 The incidence of symptomatic recurrence after treatment can be as high as 60% at 12 months.4 Despite substantial data supporting the role of sexual transmission of . . .